Stram Daniel O, Yuan Jian-Min, Chan Kenneth K, Gao Yu-Tang, Ross Ronald K, Yu Mimi C
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Nutr Cancer. 2007;57(2):123-9. doi: 10.1080/01635580701273998.
Diet may be a modifier of smoking-related cancer risk, with protective effects of intake of fruits and vegetables and associated antioxidants found in many observational studies. We previously reported serum beta-cryptoxanthin levels being inversely associated with smoking-related lung cancer incidence in a cohort of Chinese men. We noted, however, that serum beta-cryptoxanthin is negatively correlated with smoking. Since self-reports of smoking intensity undoubtedly contain errors, this negative correlation indicates a potential bias in assessing the effects of beta-cryptoxanthin, due to confounding with the unmeasured (residual) portion of cigarette exposure. We evaluated cotinine levels in pre-diagnostic spot urine samples to attempt to improve smoking assessment. We noted that urinary cotinine levels correlated significantly with cigarette consumption overall and that cotinine was strongly predictive of lung cancer risk. Urinary cotinine, however, was not as strong a predictor of lung cancer risk in current smokers as were self-reports of cigarette consumption and cotinine remained only a marginally significant predictor of lung cancer risk after adjustment for self-reports. An apparent benefit of beta-cryptoxanthin remained evident when including both urinary cotinine and self-reported cigarette consumption and cotinine in the statistical model. However, we conclude that cotinine measured from a single spot urine seems to have only limited value in augmenting self-reports of cigarette consumption so that, at present, the apparent protective effects of beta-cryptoxanthin, as seen in our own study, should continue to be regarded as unproven. We believe that future epidemiological evaluation of the association between beta-cryptoxanthin (and other antioxidants) and reduced lung cancer risk must utilize improved biomarkers to augment smokers' own self-reports of smoking amount.
饮食可能是吸烟相关癌症风险的一个影响因素,许多观察性研究发现摄入水果、蔬菜及相关抗氧化剂具有保护作用。我们之前报道过,在中国男性队列中,血清β-隐黄质水平与吸烟相关肺癌发病率呈负相关。然而,我们注意到血清β-隐黄质与吸烟呈负相关。由于吸烟强度的自我报告无疑存在误差,这种负相关表明在评估β-隐黄质的作用时可能存在偏差,这是由于与未测量的(残余的)香烟暴露部分存在混杂因素。我们评估了诊断前即时尿样中的可替宁水平,试图改善吸烟评估。我们注意到尿中可替宁水平与总体香烟消费量显著相关,并且可替宁能强烈预测肺癌风险。然而,对于当前吸烟者,尿中可替宁对肺癌风险的预测能力不如香烟消费量的自我报告,并且在对自我报告进行调整后,可替宁对肺癌风险的预测仅略有显著性。当在统计模型中同时纳入尿中可替宁和自我报告的香烟消费量及可替宁时,β-隐黄质的明显益处仍然很明显。然而,我们得出结论,单次即时尿样中测得的可替宁在增强香烟消费量的自我报告方面似乎只有有限的价值,因此,目前,如我们自己的研究所见,β-隐黄质的明显保护作用应继续被视为未经证实。我们认为,未来关于β-隐黄质(及其他抗氧化剂)与降低肺癌风险之间关联的流行病学评估必须利用改进的生物标志物来增强吸烟者对吸烟量的自我报告。